Among mutationally activated RAS genes (HRAS, KRAS, and NRAS), KRAS is the predominant isoform and is exclusively mutated in pancreatic ductal adenocarcinoma (PDAC) [8]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.